ICCM
IceCure Medical Ltd
NASDAQ · Healthcare · Medical - Devices · IL
$2.23
+1.36%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.9M | 3.4M | 3.3M | 3.2M | 3.1M |
| Cost of Revenue | 2.5M | 2.2M | 1.8M | 1.9M | 1.6M |
| Gross Profit | 1.4M | 1.2M | 1.5M | 1.3M | 1.4M |
| Operating Expenses | |||||
| R&D Expense | 8.3M | 7.4M | 7.1M | 8.3M | 9.1M |
| SG&A Expense | 9.8M | 8.9M | 10.1M | 8.6M | 9.1M |
| General & Admin Expense | 8.4M | 7.8M | 8.9M | 4.2M | 8.0M |
| Selling & Marketing Expense | 1.4M | 1.0M | 1.1M | 4.4M | 1.0M |
| Other Expenses | 5.2M | — | — | — | — |
| Total Operating Expenses | 23.4M | 16.3M | 17.1M | 16.9M | 18.2M |
| Cost and Expenses | 25.9M | 18.5M | 19.0M | 18.8M | 19.8M |
| Operating Income (EBIT) | (22.0M) | (15.1M) | (15.7M) | (15.6M) | (16.7M) |
| Non-Operating | |||||
| Interest Income | — | 37.0K | 378.0K | 924.0K | — |
| Interest Expense | 157.0K | — | — | — | — |
| Net Interest Income | (157.0K) | 37.0K | 378.0K | 924.0K | — |
| Other Non-Op Income/Expense | 5.1M | 37.0K | 378.0K | 924.0K | (239.0K) |
| Non-Operating Income (excl Interest) | (5.2M) | — | — | — | (239.0K) |
| EBT (Pre-Tax Income) | (16.9M) | (15.1M) | (15.3M) | (14.7M) | (17.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (16.9M) | (15.1M) | (15.3M) | (14.7M) | (17.0M) |
| Earnings from Cont. Ops | (16.9M) | (15.1M) | (15.3M) | (14.7M) | (17.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (16.9M) | (15.1M) | (15.3M) | (14.7M) | (17.0M) |
| Per Share | |||||
| Basic EPS | ($6.72) | ($7.10) | ($9.00) | ($9.60) | ($13.69) |
| Diluted EPS | ($6.76) | ($7.10) | ($9.00) | ($9.60) | ($13.69) |
| Revenue Per Share | $1.28 | $1.59 | $1.94 | $2.12 | $2.49 |
| Shares | |||||
| Basic Shares Outstanding | 3.1M | 2.1M | 1.7M | 1.5M | 1.2M |
| Diluted Shares Outstanding | 3.1M | 2.1M | 1.7M | 1.5M | 1.2M |
| Profitability Metrics | |||||
| EBITDA | (16.4M) | (14.8M) | (15.4M) | (15.3M) | (16.5M) |
| D&A | 284.0K | 295.0K | 332.0K | 323.0K | — |
| EBIT | (16.7M) | (15.1M) | (15.7M) | (15.6M) | (16.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026